LTRN Lantern Pharma Inc

Price (delayed)

$1.39

Market cap

$17.77M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.62

Enterprise value

$11.15M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 4
Highlights
The company's debt has shrunk by 73% YoY and by 33% QoQ
The company's net income fell by 17% QoQ but it rose by 3.1% YoY
Lantern Pharma's EPS has decreased by 12% from the previous quarter but it has increased by 9% YoY
The equity has plunged by 193% from the previous quarter and by 126% YoY
The quick ratio has contracted by 48% YoY

Key stats

What are the main financial stats of LTRN

LTRN stock price

How has the Lantern Pharma stock price performed over time
Intraday
2.21%
1 week
-27.98%
1 month
-40.6%
1 year
-65.85%
YTD
-54.13%
QTD
-66.67%

Financial performance

How have Lantern Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$15.47M
Net income
-$18.65M
Gross margin
N/A
Net margin
N/A
The operating income has increased by 25% year-on-year and by 7% since the previous quarter
The company's net income fell by 17% QoQ but it rose by 3.1% YoY

Price vs fundamentals

How does LTRN's price correlate with its fundamentals

Growth

What is Lantern Pharma's growth rate over time

Valuation

What is Lantern Pharma stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Lantern Pharma's EPS has decreased by 12% from the previous quarter but it has increased by 9% YoY
The equity has plunged by 193% from the previous quarter and by 126% YoY

Efficiency

How efficient is Lantern Pharma business performance
The ROE has plunged by 130% from the previous quarter
Lantern Pharma's return on assets has shrunk by 126% YoY and by 43% QoQ

Dividends

What is LTRN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for LTRN.

Financial health

How did Lantern Pharma financials performed over time
The total assets is 27% smaller than the total liabilities
The total liabilities has surged by 141% year-on-year
The total assets has dropped by 51% year-on-year but it is up by 19% since the previous quarter
The company's debt is 101% higher than its equity
The debt to equity has plunged by 200% YoY and by 150% from the previous quarter
The equity has plunged by 193% from the previous quarter and by 126% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.